19 related articles for article (PubMed ID: 38682951)
1. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma.
Ju MJ; Qiu SJ; Gao Q; Fan J; Cai MY; Li YW; Tang ZY
Cancer Sci; 2009 Jul; 100(7):1267-74. PubMed ID: 19432885
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
BMC Cancer; 2024 Jan; 24(1):142. PubMed ID: 38287290
[TBL] [Abstract][Full Text] [Related]
3. Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Rohr-Udilova N; Tsuchiya K; Timelthaler G; Salzmann M; Meischl T; Wöran K; Stift J; Herac M; Schulte-Hermann R; Peck-Radosavljevic M; Sieghart W; Eferl R; Jensen-Jarolim E; Trauner M; Pinter M
Hepatol Commun; 2021 Nov; 5(11):1939-1952. PubMed ID: 34558826
[TBL] [Abstract][Full Text] [Related]
4. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.
Rohr-Udilova N; Klinglmüller F; Schulte-Hermann R; Stift J; Herac M; Salzmann M; Finotello F; Timelthaler G; Oberhuber G; Pinter M; Reiberger T; Jensen-Jarolim E; Eferl R; Trauner M
Sci Rep; 2018 Apr; 8(1):6220. PubMed ID: 29670256
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).
Li M; Li H; Zhou C; Li X; Gong J; Chen C; Zhang Y
Medicine (Baltimore); 2021 Oct; 100(39):e27332. PubMed ID: 34596136
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Yao Q; Bao X; Xue R; Liu H; Liu H; Li J; Dong J; Duan Z; Ren M; Zhao J; Song Q; Yu H; Zhu Y; Lu J; Meng Q
Medicine (Baltimore); 2017 Apr; 96(17):e6735. PubMed ID: 28445292
[TBL] [Abstract][Full Text] [Related]
7. Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Pavlov S; Ye W; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
J Vis Exp; 2024 Apr; (206):. PubMed ID: 38682951
[TBL] [Abstract][Full Text] [Related]
8. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication.
Nishida N; Kudo M
Oncology; 2017; 92 Suppl 1():40-49. PubMed ID: 27764823
[TBL] [Abstract][Full Text] [Related]
9. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma.
Lee SK; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638613
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]